Insulin resistance and blood flow after stent for heart attack in type 2 diabetes
Part of Heart & circulation clinical trials.
This study looks at whether insulin resistance (when the body doesn't use insulin well) is linked to poor blood flow after a stent procedure in people with type 2 diabetes who have had a heart attack. It might help doctors understand why some people have worse outcomes after this treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have type 2 diabetes.
- You are having a heart attack (STEMI) and are scheduled for a stent procedure to open the blocked artery.
- You have not had a previous heart attack or heart failure.
- You have not had a stent or bypass surgery before.
- You do not have severe liver, kidney, or other serious health problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at new blood tests (biomarkers) that may predict whether blood flow will be blocked again after a stent procedure for a heart attack. It could help doctors improve treatment and recovery.
This study looks at how certain blood tests differ in people with diabetes who have a severe heart attack (STEMI) and receive emergency angioplasty (primary PCI). The goal is to find markers that may help predict outcomes and guide future treatment.
This study compares two ways to restore blood flow to the heart—stent placement (PCI) versus bypass surgery (CABG)—in people with diabetes and significant multi-vessel coronary artery disease. It looks at outcomes using both standard heart tests and additional imaging/functional measurements to guide the best revascularization strategy.
This trial compares how well people with type 2 diabetes recover after a heart attack treated with a stent procedure, based on whether they were on insulin or oral diabetes pills before the heart attack. The goal is to see if one type of diabetes treatment leads to better short-term outcomes.
This trial compares two ways to guide heart stent placement in people with diabetes. One method uses a special camera inside the artery (IVI), the other uses standard X-ray pictures. The goal is to see which leads to better outcomes.
This study measures how your body handles sugar and related hormones in people after a new STEMI heart attack, and compares them with people who do not have diabetes or have prediabetes. The goal is to better understand metabolic changes after the event, which could help future care.
Hear when a new STEMI trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.